Mr Blake has led the strategic development and commercialization of several products across a range of therapeutic categories. Throughout his near 20 years working in healthcare Greg has built a foundation of knowledge across marketing and the entire commercial value chain. His work with Rhythm Biosciences as General Manager led the company through the establishment of the pre-launch pathway and commercialization planning for both domestic and international markets.
Greg Blake
Follow
Get notifications in MyBN when activity occurs.
Greg Blake
Executive Director / Zelira Therapeutics
Lists and Charts
Revenue
Rank | Company | # | |
---|---|---|---|
164th | Zelira Therapeutics | $1.02m | |
166th | PharmAust | $841.71k | |
167th | - | Strategic Elements | $725.58k |
168th | Roots Sustainable Agricultural Technologies | $630.26k | |
169th | BauMart Holdings | $505.68k |
196 public companies - industrial WA ranked by total revenue
Roles
Year started and most recent title
Total Shareholder Return as at 02/12/24
Rank | Company | 1 Yr | 5 Yr |
---|---|---|---|
1221st | Spenda">Spenda | -28.57% | 4.56% |
1222nd | Z Energy">Z Energy | -28.57% | -42.42% |
1223rd | Zelira Therapeutics">Zelira Therapeutics | -28.57% | -42.42% |
1224th | AVA Risk Group">AVA Risk Group | -28.58% | 7.42% |
1225th | Elanor Investors Group">Elanor Investors Group | -28.67% | -12.83% |
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
NEW ROLE: Executive Director, Z Energy | 14 Aug 2024 | |
NEW ROLE: Executive Director, Zelira Therapeutics | 14 Aug 2024 |
Related Information
Access to our data for Greg Blake is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Greg Blake is linked to 2 organisations which are included in 2 lists - Public Companies - non WA and Public Companies - Industrial WA.
To see the data you will need to Subscribe.
X